Improving the capture and reporting of adverse events in clinical trials of non-pharmacological interventions: learnings from the PaCCSC/CST membership
Abstract Background Accurate capture and reporting of adverse events (AEs) in clinical trials is critical to understanding the potential harms of prospective interventions. Current AE-reporting frameworks are specifically constructed for pharmacological interventions and adaptation of these framewor...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Trials |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13063-025-08801-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849390041135054848 |
|---|---|
| author | Rayan Saleh Moussa Jack Power Vanessa Yenson Belinda Fazekas Celia Marston Annmarie Hosie Layla Edwards Domenica Disalvo Linda Brown Imelda Gilmore John Stubbs Andrea Cross Sally Fielding Meera R. Agar |
| author_facet | Rayan Saleh Moussa Jack Power Vanessa Yenson Belinda Fazekas Celia Marston Annmarie Hosie Layla Edwards Domenica Disalvo Linda Brown Imelda Gilmore John Stubbs Andrea Cross Sally Fielding Meera R. Agar |
| author_sort | Rayan Saleh Moussa |
| collection | DOAJ |
| description | Abstract Background Accurate capture and reporting of adverse events (AEs) in clinical trials is critical to understanding the potential harms of prospective interventions. Current AE-reporting frameworks are specifically constructed for pharmacological interventions and adaptation of these frameworks imparts the risk of excluding AEs unique to non-pharmacological interventions that have not yet been defined. As a result, clinical trials of non-pharmacological interventions seldom include a systematic method to capturing and reporting AEs, often using no method at all. These gaps make it likely that AEs in trials of non-pharmacological interventions are underreported, providing insufficient information about the safety of such interventions prior to their implementation in clinical practice. In addition, clinical trials focus primarily on participants receiving the intervention, with current AE-reporting frameworks not designed to capture potential harms to other personnel involved (i.e. family/carers, and clinical and research staff). A series of collaborative group discussions with consumers and interdisciplinary clinical trialists, and case study analyses were conducted to explore gaps in the capture and reporting of AEs specific to non-pharmacological trials, and their mitigation. Main body Two case examples are provided. The first case example highlights that current methods are inadequate, resulting in inconsistencies in capturing AEs, influenced by the environmental context of the clinical trial. The second case example highlights the need for both systematic and simplified AE-reporting frameworks, particularly for clinical trials conducted in medically complex populations where participants may be at high risk of experiencing AEs. We recommend future trials of non-pharmacological interventions adopt a four-step framework that incorporates: (1) enhanced trial protocol development to define the participant, environmental context in which the intervention is taking place and identify other personnel involved; (2) pre-specify anticipated AEs in trial protocol; (3) selection of the most appropriate measurement system to define, report and grade AEs; and (4) develop corrective and preventative action plans. Conclusion We provide recommendations for an AE-reporting framework for future trials that encompass risks unique to non-pharmacological interventions and all individuals involved. By focusing on these directions, we can streamline the process of capturing and reporting AEs and contribute to more impactful and sustainable outcomes. |
| format | Article |
| id | doaj-art-448be3290577439ba015a66a1ad0f624 |
| institution | Kabale University |
| issn | 1745-6215 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | BMC |
| record_format | Article |
| series | Trials |
| spelling | doaj-art-448be3290577439ba015a66a1ad0f6242025-08-20T03:41:47ZengBMCTrials1745-62152025-03-012611710.1186/s13063-025-08801-1Improving the capture and reporting of adverse events in clinical trials of non-pharmacological interventions: learnings from the PaCCSC/CST membershipRayan Saleh Moussa0Jack Power1Vanessa Yenson2Belinda Fazekas3Celia Marston4Annmarie Hosie5Layla Edwards6Domenica Disalvo7Linda Brown8Imelda Gilmore9John Stubbs10Andrea Cross11Sally Fielding12Meera R. Agar13Research Institute for Innovative Solutions for Wellbeing and Health, IMPACCT − Improving Palliative, Aged and Chronic Care Through Clinical Research and Translation, Faculty of Health, University of Technology SydneyResearch Institute for Innovative Solutions for Wellbeing and Health, IMPACCT − Improving Palliative, Aged and Chronic Care Through Clinical Research and Translation, Faculty of Health, University of Technology SydneyResearch Institute for Innovative Solutions for Wellbeing and Health, IMPACCT − Improving Palliative, Aged and Chronic Care Through Clinical Research and Translation, Faculty of Health, University of Technology SydneyResearch Institute for Innovative Solutions for Wellbeing and Health, IMPACCT − Improving Palliative, Aged and Chronic Care Through Clinical Research and Translation, Faculty of Health, University of Technology SydneyResearch Institute for Innovative Solutions for Wellbeing and Health, IMPACCT − Improving Palliative, Aged and Chronic Care Through Clinical Research and Translation, Faculty of Health, University of Technology SydneyResearch Institute for Innovative Solutions for Wellbeing and Health, IMPACCT − Improving Palliative, Aged and Chronic Care Through Clinical Research and Translation, Faculty of Health, University of Technology SydneyResearch Institute for Innovative Solutions for Wellbeing and Health, IMPACCT − Improving Palliative, Aged and Chronic Care Through Clinical Research and Translation, Faculty of Health, University of Technology SydneyResearch Institute for Innovative Solutions for Wellbeing and Health, IMPACCT − Improving Palliative, Aged and Chronic Care Through Clinical Research and Translation, Faculty of Health, University of Technology SydneyResearch Institute for Innovative Solutions for Wellbeing and Health, IMPACCT − Improving Palliative, Aged and Chronic Care Through Clinical Research and Translation, Faculty of Health, University of Technology SydneyResearch Institute for Innovative Solutions for Wellbeing and Health, IMPACCT − Improving Palliative, Aged and Chronic Care Through Clinical Research and Translation, Faculty of Health, University of Technology SydneyResearch Institute for Innovative Solutions for Wellbeing and Health, IMPACCT − Improving Palliative, Aged and Chronic Care Through Clinical Research and Translation, Faculty of Health, University of Technology SydneyResearch Institute for Innovative Solutions for Wellbeing and Health, IMPACCT − Improving Palliative, Aged and Chronic Care Through Clinical Research and Translation, Faculty of Health, University of Technology SydneyResearch Institute for Innovative Solutions for Wellbeing and Health, IMPACCT − Improving Palliative, Aged and Chronic Care Through Clinical Research and Translation, Faculty of Health, University of Technology SydneyResearch Institute for Innovative Solutions for Wellbeing and Health, IMPACCT − Improving Palliative, Aged and Chronic Care Through Clinical Research and Translation, Faculty of Health, University of Technology SydneyAbstract Background Accurate capture and reporting of adverse events (AEs) in clinical trials is critical to understanding the potential harms of prospective interventions. Current AE-reporting frameworks are specifically constructed for pharmacological interventions and adaptation of these frameworks imparts the risk of excluding AEs unique to non-pharmacological interventions that have not yet been defined. As a result, clinical trials of non-pharmacological interventions seldom include a systematic method to capturing and reporting AEs, often using no method at all. These gaps make it likely that AEs in trials of non-pharmacological interventions are underreported, providing insufficient information about the safety of such interventions prior to their implementation in clinical practice. In addition, clinical trials focus primarily on participants receiving the intervention, with current AE-reporting frameworks not designed to capture potential harms to other personnel involved (i.e. family/carers, and clinical and research staff). A series of collaborative group discussions with consumers and interdisciplinary clinical trialists, and case study analyses were conducted to explore gaps in the capture and reporting of AEs specific to non-pharmacological trials, and their mitigation. Main body Two case examples are provided. The first case example highlights that current methods are inadequate, resulting in inconsistencies in capturing AEs, influenced by the environmental context of the clinical trial. The second case example highlights the need for both systematic and simplified AE-reporting frameworks, particularly for clinical trials conducted in medically complex populations where participants may be at high risk of experiencing AEs. We recommend future trials of non-pharmacological interventions adopt a four-step framework that incorporates: (1) enhanced trial protocol development to define the participant, environmental context in which the intervention is taking place and identify other personnel involved; (2) pre-specify anticipated AEs in trial protocol; (3) selection of the most appropriate measurement system to define, report and grade AEs; and (4) develop corrective and preventative action plans. Conclusion We provide recommendations for an AE-reporting framework for future trials that encompass risks unique to non-pharmacological interventions and all individuals involved. By focusing on these directions, we can streamline the process of capturing and reporting AEs and contribute to more impactful and sustainable outcomes.https://doi.org/10.1186/s13063-025-08801-1Adverse eventsNon-pharmacologicalRisk managementClinical trialsInterventionHarm |
| spellingShingle | Rayan Saleh Moussa Jack Power Vanessa Yenson Belinda Fazekas Celia Marston Annmarie Hosie Layla Edwards Domenica Disalvo Linda Brown Imelda Gilmore John Stubbs Andrea Cross Sally Fielding Meera R. Agar Improving the capture and reporting of adverse events in clinical trials of non-pharmacological interventions: learnings from the PaCCSC/CST membership Trials Adverse events Non-pharmacological Risk management Clinical trials Intervention Harm |
| title | Improving the capture and reporting of adverse events in clinical trials of non-pharmacological interventions: learnings from the PaCCSC/CST membership |
| title_full | Improving the capture and reporting of adverse events in clinical trials of non-pharmacological interventions: learnings from the PaCCSC/CST membership |
| title_fullStr | Improving the capture and reporting of adverse events in clinical trials of non-pharmacological interventions: learnings from the PaCCSC/CST membership |
| title_full_unstemmed | Improving the capture and reporting of adverse events in clinical trials of non-pharmacological interventions: learnings from the PaCCSC/CST membership |
| title_short | Improving the capture and reporting of adverse events in clinical trials of non-pharmacological interventions: learnings from the PaCCSC/CST membership |
| title_sort | improving the capture and reporting of adverse events in clinical trials of non pharmacological interventions learnings from the paccsc cst membership |
| topic | Adverse events Non-pharmacological Risk management Clinical trials Intervention Harm |
| url | https://doi.org/10.1186/s13063-025-08801-1 |
| work_keys_str_mv | AT rayansalehmoussa improvingthecaptureandreportingofadverseeventsinclinicaltrialsofnonpharmacologicalinterventionslearningsfromthepaccsccstmembership AT jackpower improvingthecaptureandreportingofadverseeventsinclinicaltrialsofnonpharmacologicalinterventionslearningsfromthepaccsccstmembership AT vanessayenson improvingthecaptureandreportingofadverseeventsinclinicaltrialsofnonpharmacologicalinterventionslearningsfromthepaccsccstmembership AT belindafazekas improvingthecaptureandreportingofadverseeventsinclinicaltrialsofnonpharmacologicalinterventionslearningsfromthepaccsccstmembership AT celiamarston improvingthecaptureandreportingofadverseeventsinclinicaltrialsofnonpharmacologicalinterventionslearningsfromthepaccsccstmembership AT annmariehosie improvingthecaptureandreportingofadverseeventsinclinicaltrialsofnonpharmacologicalinterventionslearningsfromthepaccsccstmembership AT laylaedwards improvingthecaptureandreportingofadverseeventsinclinicaltrialsofnonpharmacologicalinterventionslearningsfromthepaccsccstmembership AT domenicadisalvo improvingthecaptureandreportingofadverseeventsinclinicaltrialsofnonpharmacologicalinterventionslearningsfromthepaccsccstmembership AT lindabrown improvingthecaptureandreportingofadverseeventsinclinicaltrialsofnonpharmacologicalinterventionslearningsfromthepaccsccstmembership AT imeldagilmore improvingthecaptureandreportingofadverseeventsinclinicaltrialsofnonpharmacologicalinterventionslearningsfromthepaccsccstmembership AT johnstubbs improvingthecaptureandreportingofadverseeventsinclinicaltrialsofnonpharmacologicalinterventionslearningsfromthepaccsccstmembership AT andreacross improvingthecaptureandreportingofadverseeventsinclinicaltrialsofnonpharmacologicalinterventionslearningsfromthepaccsccstmembership AT sallyfielding improvingthecaptureandreportingofadverseeventsinclinicaltrialsofnonpharmacologicalinterventionslearningsfromthepaccsccstmembership AT meeraragar improvingthecaptureandreportingofadverseeventsinclinicaltrialsofnonpharmacologicalinterventionslearningsfromthepaccsccstmembership |